BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Plexxikon Inc. Initiates Phase 1 Trial for PLX5568

  September 3, 2008

   · 

  1 min read
• Business

  BioImagene, Inc. Appoints Prominent Pathologist Dr. Robert J. Monroe as Chief Medical Officer

  September 3, 2008

   · 

  1 min read
• BioMidwest

  Medventure Management Joins Venture Firm Ampersand Ventures To Buy Out Investors; Deal Gives Medventure The Capitalization It Needs To Grow As An International Medical Device Developer And Contract Manufacturer

  September 3, 2008

   · 

  1 min read
• Business

  Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors

  September 3, 2008

   · 

  1 min read
• Drug Development

  OSI Pharmaceuticals, Inc. Initiates Clinical Development Program for Anti-Diabetes Candidate, PSN821

  September 3, 2008

   · 

  1 min read
• Pharm Country

  Celgene Corporation to Present at the Thomas Weisel Partners Experts in Growth Healthcare Conference 2008

  September 3, 2008

   · 

  1 min read
• Drug Development

  Phase III U.S. Pivotal Study Results on CSL Biotherapies’ Afluria(R) Published in Vaccine

  September 3, 2008

   · 

  1 min read
• Pharm Country

  Wall Street Analyst Forum 2008 Presenter Profiles for AVANIR Pharmaceuticals and DRI Corporation

  September 3, 2008

   · 

  1 min read
• Business

  Peregrine Pharmaceuticals, Inc. to Report First Quarter FY 2009 Financial Results

  September 3, 2008

   · 

  1 min read
• Bio NC

  Alte Biosciences Files Patent for New Inflammatory Bowel Disease Drugs

  September 3, 2008

   · 

  1 min read